Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FDA Approves Marathon Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Drug
Friday, February 10, 2017The US Food and Drug Administration on Thursday approved a drug made by Marathon Pharmaceuticals to treat Duchenne muscular dystrophy DMD a devastating musclewasting disease that mainly affects young boys The drug Emflaza known generically as deflaz...
Epinomics to Collaborate with the Parker Institute for Cancer Immunotherapy at Stanford University to Bring Precision Medicine to Cancer Immunotherapies
Thursday, February 09, 2017Researchers from Epinomics will collaborate with the research team led by Crystal Mackall MD director of the Parker Institute for Cancer Immunotherapy at Stanford to utilize biomarkers defined by Epinomics immune intelligence framework to improve out...
Acceliant Awarded WHO Drug Medical Coding Certification - Joins Select League of Clinical Trial Solutions Providers
Thursday, February 09, 2017Acceliant the global leader in clinical trial management solutions has announced that it has received the prestigious World Health Organization WHO Drug Dictionaries Medical Coding certification The WHO Drug Dictionary is an international classificat...
Restylane® Refyne and Defyne Dermal Fillers -- FDA-Approved Next-Generation Treatment for Diminishing Nasolabial Folds Now Available at Contour Dermatology & Cosmetic Surgery Center
Thursday, February 09, 2017Nasolabial folds or laugh lines as theyre commonly known are rarely a source of humor Fortunately leading global pharmaceutical company Galderma recently received FDA approval of two new products intended to treat moderate to severe facial wrinkles a...
Vyome Biosciences Announces Top-Line Results from Phase 1 Study of VB-1953
Wednesday, February 08, 2017Vyome Biosciences a clinicalstage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes today announced topline data from its phase clinical trial evaluating VB a topically administered g...
FDA Approves Amgen's Parsabiv™ (Etelcalcetide) for Secondary Hyperparathyroidism
Wednesday, February 08, 2017Amgen today announced that the US Food and Drug Administration FDA has approved Parsabiv etelcalcetide for the treatment of secondary hyperparathyroidism HPT in adult patients with chronic kidney disease CKD on hemodialysis Parsabiv is the first ther...
AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery
Wednesday, February 08, 2017AMRI a global contract research and manufacturing organization working to improve patient outcomes and quality of life has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass s...
Quotient Clinical expands into USA through acquisition of SeaView Research, the specialist clinical pharmacology business
Tuesday, February 07, 2017Quotient Clinical Quotient the early phase drug development services provider today announces that it has acquired SeaView Research SeaView expanding its operations into the USA The acquisition combines Quotient and SeaViews complementary customer po...
Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light-activated AU-011 for the Treatment of Ocular Melanoma
Tuesday, February 07, 2017Aura Biosciences a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates announced today that the US Food and Drug Administration FDA has cleared the investigation...
Strata Oncology Announces Collaboration with Epizyme to Support Tazemetostat Clinical Development
Tuesday, February 07, 2017Strata Oncology a precision oncology company today announced an agreement with Epizyme to support patient identification and enrollment for Epizymes ongoing Phase clinical trial of tazemetostat in patients with relapsed or refractory nonHodgkins lym...
